Voya Investment Management LLC Medicinova Inc Transaction History

Voya Investment Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.76 - $5.14 $73,380 - $100,312	-19,516 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$5.03 - $6.31 $24,657 - $30,931	4,902 Added 33.54%	19,516 $103,000
Q2 2020 Aug 14, 2020	SELL	$3.06 - $7.06 $20,266 - $46,758	-6,623 Reduced 31.19%	14,614 $79,000
Q4 2019 Feb 14, 2020	BUY	$6.48 - $8.76 $24,811 - $33,542	3,829 Added 22.0%	21,237 $143,000
Q2 2019 Aug 14, 2019	BUY	$8.29 - $13.22 $12,294 - $19,605	1,483 Added 9.31%	17,408 $168,000
Q2 2018 Aug 14, 2018	SELL	$7.96 - $13.23 $12,489 - $20,757	-1,569 Reduced 8.97%	15,925 $127,000
Q1 2018 May 15, 2018	SELL	$6.6 - $13.91 $12,190 - $25,691	-1,847 Reduced 9.55%	17,494 $179,000
Q3 2017 Nov 14, 2017	BUY	$4.43 - $6.58 $85,680 - $127,263	19,341	19,341 $123,000

4.83M

9.4K

Ticker MNOV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,046,200
Market Cap $93.2M
Description
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.